Clinical Strategy Committee - February and March

  • 26 Mar 2024

CTC-RI hosted our February Clinical Strategy Committee centered on a new Alcohol Use Disorder proposal and the alignment with Certified Community Behavioral Health Centers in Rhode Island. Andrew Saal, MD MPH, Public Health Consultant, led the discussion of the Alcohol Use Disorder proposal. The goal of this project is to share best practices in alcohol treatment, to foster communication between community partners and patients, and to build resiliency in primary care to better manage Rhode Island substance use disorder patients. Data on the Rhode Island AE Inpatient and Emergency Room trends was presented by Dr. Barry Fabius, Chief Medical Officer, UnitedHealthcare Community Plan of Rhode Island. In addition, our audience heard from Thundermist Health Center on Alcohol and SUD impacts in ED and Inpatient Utilization, presented by Matthew Roman, MBA, LICSW, Chief Operating Officer, Thundermist Health Center.

This meeting also featured a presentation from Marti Rosenberg, Director of Policy, Planning, and Research, and Amy Hulberg, Medicaid Policy Director, both of Executive Office of Health and Human Services. This portion of the meeting was dedicated to discussing the partnerships of Certified Community Behavioral Health Clinics and other Designated Collaborating Organizations. Pano Yeracaris, MD, MPH, Chief Clinical Strategist, led a discussion on the intersection of these projects, and future directions for Rhode Island organizations.

Our March Clinical Strategy Committee focused on the Pharmacy Quality Improvement Initiatives in Rhode Island and their impacts on primary care. Kelley Sanzen, PharmD, Clinical Pharmacy Specialist with the Division of Kidney Disease and Hypertension at Brown Medicine and Stephen Kogut, PhD, MBA, Professor of Pharmacoeconomics and Managed Care Pharmacy at the University of Rhode Island, presented on several exciting pharmacy projects. These initiatives included the Safe-Effective-Efficient Use of Medication in Older Adults, Avoidance of ED/Preventable Hospitalization, Professional Continuous Glucose Monitoring, and the Diabetes-related Retinopathy & Nephropathy Screening projects. The presentations included clinical data, patient feedback, and care team well-being data from these pharmacy projects.

 View our CME page to see the recording, presentation and claim CME credits.